Ignite Creation Date:
2025-12-24 @ 12:15 PM
Ignite Modification Date:
2026-01-09 @ 12:03 PM
Study NCT ID:
NCT03526861
Status:
COMPLETED
Last Update Posted:
2025-03-11
First Post:
2018-05-04
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).
Sponsor:
Organization: